Focused ultrasound and chemotherapy improve glioblastoma survival

news-medical.net

Focused ultrasound combined with chemotherapy significantly increased overall survival for glioblastoma patients in a trial. The treatment, which uses MRI-guided focused ultrasound to open the blood-brain barrier for chemotherapy delivery, resulted in a nearly 40 percent survival increase. This marks the first demonstration of a survival benefit from this approach in brain cancer patients post-surgery. The study also showed improved progression-free survival and demonstrated the potential for using "liquid biopsies" to monitor treatment effectiveness and disease progression.


With a significance score of 5.6, this news ranks in the top 0.6% of today's 31072 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: